Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients

Chemotherapy

Volumn 47, Issue 3, 2001, Pages 153-156

  Bui, Khanh Q ^a   Ambrose, Paul G ^d   Nicolau, David P ^b   Lapin, Craig D ^c   Nightingale, Charles H ^b   Quintiliani, Richard ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d Princeton Corporate Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MEROPENEM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; GRAM NEGATIVE INFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; THIENAMYCINS;

EID: 0035048948     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063216     Document Type: Article

References (17)

1. The treatment of pulmonary infection in cystic fibrosis
2. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
3. The pharmacology of meropenem, a new carbapenem antibiotic
4. The pharmacokinetics of meropenem
5. Pharmacokinetic evaluation of imipenem combined with cilastatin in cystic fibrosis
6. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: A controlled prospective study
7. Pharmacokinetics of antimicrobial drugs in cystic fibrosis
8. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis
9. High dose treatment with antibiotics in cystic fibrosis - A reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF patients
10. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin
11. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis
12. High-performance liquid chromatography assay for meropenem in serum
13. Meropenem. A review of its antibacterial, activity, pharmacokinetic properties and clinical efficacy
14. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis
15. Pharmacokinetics in patients with cystic fibrosis
16. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide